Supplementary Table 2: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study

Name: Supplementary Table 2: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study
Creator: Taylor & Francis
Published: 2021-11-18T09:14:11+08:00

DataCite Commons2024-05-18 更新2024-07-13 收录

用药安全

慢性下背痛

数据链接：

https://tandf.figshare.com/articles/dataset/Supplementary_Table_2_Tanezumab_for_chronic_low_back_pain_a_long-term_randomized_celecoxib-controlled_Japanese_Phase_3_safety_study/17040284/1 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Table 2. Tanezumab for Chronic Low Back Pain: A Long-term, Randomized, Celecoxib-Controlled, Japanese, Phase 3, Safety Study Summary of all-causality TEAEs through week 80 (treatment + follow-up period)

提供机构：

Taylor & Francis

创建时间：

2021-11-18